Patent-family-83151383

Patent Number: CN-118234506-A

Publication Year: 2024

Application Year: 2022

Priority Year: 2021

Jurisdictions: CN

Status: Pending

Inventors:

SPROGOEE KENNETT

Applicants:

  1. Ascendis Pharma Bone Diseases AS
  2. [NORA names: Ascendis Pharma; Private Research]

Abstract

The present application relates to long-acting PTH compounds for reducing Bone Mineral Density (BMD) in patients with increased BMD, as well as specific dosing regimens and other related aspects of such long-acting PTH compounds.

Patent Family Records (1)

Long acting PTH compound treatment

Ascendis Pharma Bone Diseases AS SPROGOEE KENNETT

2024, CN-118234506-A

Data Provider: Digital Science